var data={"title":"Dextromethorphan: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Dextromethorphan: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6008?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=dextromethorphan-patient-drug-information\" class=\"drug drug_patient\">see &quot;Dextromethorphan: Patient drug information&quot;</a> and <a href=\"topic.htm?path=dextromethorphan-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Dextromethorphan: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158845\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Buckleys Cough [OTC];</li>\n      <li>Cough DM [OTC];</li>\n      <li>Creomulsion Adult [OTC] [DSC];</li>\n      <li>Creomulsion for Children [OTC] [DSC];</li>\n      <li>Delsym Cough Childrens [OTC];</li>\n      <li>Delsym [OTC];</li>\n      <li>ElixSure Cough [OTC];</li>\n      <li>GoodSense Cough DM Childrens [OTC];</li>\n      <li>GoodSense Cough DM [OTC];</li>\n      <li>Hold [OTC];</li>\n      <li>Little Colds Cough Formula [OTC];</li>\n      <li>PediaCare Childrens Long-Act [OTC];</li>\n      <li>Robafen Cough [OTC];</li>\n      <li>Robitussin 12 Hour Cough Child [OTC];</li>\n      <li>Robitussin 12 Hour Cough [OTC];</li>\n      <li>Robitussin Childrens Cough LA [OTC];</li>\n      <li>Robitussin CoughGels [OTC] [DSC];</li>\n      <li>Robitussin Lingering CoughGels [OTC];</li>\n      <li>Robitussin Lingering LA Cough [OTC];</li>\n      <li>Scot-Tussin Diabetes CF [OTC];</li>\n      <li>Silphen DM Cough [OTC];</li>\n      <li>Simply Cough [OTC] [DSC];</li>\n      <li>Triaminic Long Acting Cough [OTC];</li>\n      <li>Trocal Cough Suppressant [OTC];</li>\n      <li>Vicks Nature Fusion Cough [OTC] [DSC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158874\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antitussive;</li>\n      <li>\n        N-Methyl-D-Aspartate Receptor Antagonist</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158848\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Cough suppressant:</b> Oral: 10 to 20 mg every 4 hours <b>or</b> 20 to 30 mg every 6 to 8 hours; extended release: 60 mg twice daily; maximum: 120 mg/24 hours</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158862\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=dextromethorphan-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Dextromethorphan: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Cough suppressant:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&lt;4 years: Not for OTC use</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">4 to 6 years (syrup): 2.5 to 7.5 mg every 4 to 8 hours; extended release is 15 mg twice daily (maximum: 30 mg/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">6 to 12 years: 5 to 10 mg every 4 hours or 15 mg every 6 to 8 hours; extended release is 30 mg twice daily (maximum: 60 mg/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Children &gt;12 years: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158849\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49892038\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustment provided in manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49892039\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustment provided in manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158835\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robafen Cough: 15 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin CoughGels: 15 mg [DSC] [contains brilliant blue fcf (fd&amp;c blue #1)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin Lingering CoughGels: 15 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40, polyethylene glycol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, Oral, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">ElixSure Cough: 7.5 mg/5 mL (120 mL) [alcohol free; contains carbomer 934p, propylene glycol, propylparaben; cherry bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, Oral, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Buckleys Cough: 12.5 mg/5 mL (118 mL) [alcohol free, sugar free; contains butylparaben, menthol, propylparaben, saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Little Colds Cough Formula: 7.5 mg/mL (30 mL) [alcohol free, dye free, saccharin free; contains sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">PediaCare Childrens Long-Act: 7.5 mg/5 mL (118 mL) [contains brilliant blue fcf (fd&amp;c blue #1), saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin Lingering LA Cough: 15 mg/5 mL (118 mL) [contains alcohol, usp, fd&amp;c red #40, menthol, saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Scot-Tussin Diabetes CF: 10 mg/5 mL (118.3 mL [DSC], 480 mL, 3780 mL) [alcohol free, dye free, fructose free, sodium free, sorbitol free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Long Acting Cough: 7.5 mg/5 mL (118 mL) [alcohol free, dye free, pseudoephedrine free; contains benzoic acid, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Vicks Nature Fusion Cough: 15 mg/15 mL (236 mL [DSC]) [alcohol free, dye free, gluten free; contains polyethylene glycol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid Extended Release, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym: 30 mg/5 mL (89 mL [DSC]) [alcohol free; contains brilliant blue fcf (fd&amp;c blue #1), disodium edta, methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym: 30 mg/5 mL (89 mL [DSC], 148 mL [DSC]) [alcohol free; contains edetate disodium, fd&amp;c yellow #6 (sunset yellow), methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben; orange flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lozenge, Mouth/Throat, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hold: 5 mg (10 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hold: 5 mg (10 ea) [cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Trocal Cough Suppressant: 7.5 mg (1 ea) [cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Strip, Oral, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Long Acting Cough: 7.5 mg (14 ea, 16 ea) [contains alcohol, usp, fd&amp;c red #40; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Long Acting Cough: 7.5 mg (14 ea) [contains alcohol, usp, fd&amp;c red #40, isopropyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension Extended Release, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cough DM: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL) [alcohol free; contains fd&amp;c yellow #10 aluminum lake, methylparaben, polysorbate 80, propylparaben, sodium metabisulfite; orange flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL, 148 mL) [alcohol free; contains brilliant blue fcf (fd&amp;c blue #1), disodium edta, methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL, 148 mL) [alcohol free; contains edetate disodium, fd&amp;c yellow #6 (sunset yellow), methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben; orange flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym Cough Childrens: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL, 148 mL) [alcohol free; contains brilliant blue fcf (fd&amp;c blue #1), edetate disodium, methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben, soybean oil; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym Cough Childrens: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL, 148 mL) [alcohol free; contains edetate disodium, fd&amp;c yellow #6 (sunset yellow), methylparaben, polyethylene glycol, polysorbate 80, propylene glycol, propylparaben, soybean oil; orange flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">GoodSense Cough DM: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (148 mL) [alcohol free, gluten free; contains fd&amp;c yellow #10 aluminum lake, methylparaben, polysorbate 80, propylparaben, sodium metabisulfite]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">GoodSense Cough DM Childrens: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL, 148 mL) [alcohol free, gluten free; contains fd&amp;c yellow #10 aluminum lake, methylparaben, polysorbate 80, propylparaben, sodium metabisulfite]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin 12 Hour Cough: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL) [alcohol free; contains brilliant blue fcf (fd&amp;c blue #1), methylparaben, polysorbate 80, propylparaben, sodium metabisulfite]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin 12 Hour Cough: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL) [alcohol free; contains fd&amp;c yellow #10 (quinoline yellow), methylparaben, polysorbate 80, propylparaben, sodium metabisulfite]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin 12 Hour Cough Child: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL) [alcohol free; contains brilliant blue fcf (fd&amp;c blue #1), methylparaben, polysorbate 80, propylparaben, sodium metabisulfite]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: Dextromethorphan polistirex [equivalent to dextromethorphan hydrobromide 30 mg/5 mL] (89 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Syrup, Oral, as hydrobromide: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Creomulsion Adult: 20 mg/15 mL (118 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Creomulsion for Children: 5 mg/5 mL (118 mL [DSC]) [cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Robitussin Childrens Cough LA: 7.5 mg/5 mL (118 mL) [alcohol free; contains fd&amp;c red #40, propylene glycol, saccharin sodium, sodium benzoate; fruit punch flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Silphen DM Cough: 10 mg/5 mL (118 mL) [contains alcohol, usp; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Simply Cough: 5 mg/5 mL (120 mL [DSC]) [alcohol free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Long Acting Cough: 7.5 mg/5 mL (118 mL [DSC]) [alcohol free, dye free; contains benzoic acid, edetate disodium, propylene glycol]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158824\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49892050\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Shake extended release suspension well before use. Only use dosing cup provided to measure liquid doses.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158836\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Cough (suppressant):</b> Temporary control of cough due to minor throat and bronchial irritation associated with the common cold or inhaled irritants; temporary relief of cough impulse to improve sleep (extended release formulations)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158878\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Benylin may be confused with Benadryl, Ventolin </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Delsym may be confused with Delfen, Desyrel</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158830\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">Central nervous system: Confusion, excitement, irritability, nervousness, serotonin syndrome</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158839\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Concurrent administration with or within 2 weeks of discontinuing an MAO inhibitor </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5366785\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&bull; Serotonin syndrome: Symptoms of agitation, confusion, hallucinations, hyper-reflexia, myoclonus, shivering, and tachycardia may occur with concomitant proserotonergic drugs (ie, SSRIs/SNRIs or triptans); especially with higher dextromethorphan doses.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; CYP2D6 poor metabolizers: Dextromethorphan is metabolized by hepatic CYP2D6. Poor metabolizers of CYP2D6 may have exaggerated or prolonged effects of dextromethorphan. Increased risk may be seen with concomitant use of potent CYP2D6 inhibitors; use with caution (Abduljalil 2010; Jurica 2012; Sager 2014; Zhou 2009).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Debilitated patients: Use with caution in patients who are sedated, debilitated or confined to a supine position.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Use with caution in atopic children. Not for OTC use in children &lt;4 years of age.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Tartrazine: Some products may contain tartrazine.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Abuse/misuse: Healthcare providers should be alert to problems of abuse or misuse. Abuse can cause death, brain damage, seizure, loss of consciousness, and irregular heartbeat.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Self-medication (OTC use): When used for self medication (OTC) notify healthcare provider if symptoms do not improve within 7 days, or are accompanied by fever, rash or persistent headache. Do not use for persistent or chronic cough (as with smoking, asthma, chronic bronchitis, emphysema) or if cough is accompanied by excessive phlegm unless directed to do so by healthcare provider.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158870\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Substrate</b> of CYP2B6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP2D6 (major), CYP2E1 (minor), CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158831\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=8893&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ajmaline: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antiemetics (5HT3 Antagonists): May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antipsychotic Agents: Serotonin Modulators may enhance the adverse/toxic effect of Antipsychotic Agents. Specifically, serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Antipsychotic Agents may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Asunaprevir: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cobicistat: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dapoxetine: May enhance the adverse/toxic effect of Serotonin Modulators.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Darunavir: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Imatinib: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lumefantrine: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Memantine: NMDA Receptor Antagonists may enhance the adverse/toxic effect of Memantine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metaxalone: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methylene Blue: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methylphenidate: May enhance the adverse/toxic effect of Serotonin Modulators. Specifically, the risk of serotonin syndrome or serotonin toxicity may be increased.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Monoamine Oxidase Inhibitors: May enhance the serotonergic effect of Dextromethorphan. This may cause serotonin syndrome.<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Opioid Analgesics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Panobinostat: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Management: Avoid concurrent use of sensitive CYP2D6 substrates when possible, particularly those substrates with a narrow therapeutic index.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Parecoxib: May increase the serum concentration of Dextromethorphan.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Peginterferon Alfa-2b may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Perhexiline: CYP2D6 Substrates (High risk with Inhibitors) may increase the serum concentration of Perhexiline. Perhexiline may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">QuiNIDine: May increase the serum concentration of Dextromethorphan. Management: Avoid concurrent use of these agents when possible, unless the increased psychoactive effects of dextromethorphan are desired.  Since codeine activation is also inhibited by quinidine, codeine is unlikely to be suitable as an alternative antitussive.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">QuiNINE: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Selective Serotonin Reuptake Inhibitors: May enhance the serotonergic effect of Dextromethorphan. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Dextromethorphan. Management: Avoid the concurrent use of dextromethorphan and SSRIs, particularly fluoxetine and paroxetine, when possible.  The risk for this interaction may persist for several weeks following discontinuation of fluoxetine or paroxetine.<b> Exceptions: </b>FluvoxaMINE.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.<b> Exceptions: </b>Nicergoline; Tedizolid.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tipranavir: May increase the serum concentration of Dextromethorphan. Management: Consider avoiding dextromethorphan in patients taking tipranavir. If combined, monitor closely for increased dextromethorphan effects/toxicities.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">TraMADol: Serotonin Modulators may enhance the adverse/toxic effect of TraMADol. The risk of seizures may be increased. TraMADol may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F12708268\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Dextromethorphan is metabolized in the liver via CYP2D6 and CYP3A enzymes. The activity of both enzymes is increased in the mother during pregnancy (Tracy 2005; Wadelius 1997). In the fetus, CYP2D6 activity is low in the fetal liver and CYP3A4 activity is present by ~17 weeks' gestation (Jacqz-Aigrain 1992).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">When an antitussive is needed during pregnancy, dextromethorphan standard at standard OTC doses is generally considered acceptable. Some sources recommend use be reserved for significant maternal need; products containing alcohol should be avoided (Chasnoff 1981; Conover 2003; Koren 1998; Ward 2005).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50781259\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Information related to the presence of dextromethorphan in breast milk has not been located. Data are not available to make recommendations for use in breastfeeding women (WHO 2002). Products containing alcohol should be avoided.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158840\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Some products may contain sodium.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158827\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Decreases the sensitivity of cough receptors and interrupts cough impulse transmission by depressing the medullary cough center through sigma receptor stimulation; structurally related to codeine </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158838\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: Antitussive: 15-30 minutes </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Duration: &le;6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic via demethylation via CYP2D6 to dextrorphan (active); CYP3A4 and CYP3A5 form smaller amounts of 3-hydroxy and 3-methoxy derivatives</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: Dextromethorphan: Extensive metabolizers: 2-4 hours; poor metabolizers: 24 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak: 2-3 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Primarily in urine as metabolites</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323103\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Robitussin Lingering CoughGels Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">15 mg (20): $5.16</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (ElixSure Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg/5 mL (120 mL): $4.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Buckleys Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">12.5 mg/5 mL (118 mL): $4.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Little Colds Cough Formula Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg/mL (30 mL): $3.89</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (PediaCare Childrens Long-Act Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg/5 mL (118 mL): $5.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Robitussin Lingering LA Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">15 mg/5 mL (118 mL): $5.32</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Scot-Tussin Diabetes CF Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 mg/5 mL (480 mL): $14.03</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Triaminic Long Acting Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg/5 mL (118 mL): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lozenge</b> (Hold Mouth/Throat)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5 mg (10): $2.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lozenge</b> (Trocal Cough Suppressant Mouth/Throat)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg (1): $0.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Strip</b> (Triaminic Long Acting Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg (14): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension Extended Release</b> (Delsym Cough Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg/5 mL (89 mL): $9.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension Extended Release</b> (Delsym Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg/5 mL (89 mL): $9.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension Extended Release</b> (Dextromethorphan Polistirex ER Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg/5 mL (89 mL): $7.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension Extended Release</b> (Robitussin 12 Hour Cough Child Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg/5 mL (89 mL): $8.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension Extended Release</b> (Robitussin 12 Hour Cough Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">30 mg/5 mL (89 mL): $8.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Robitussin Childrens Cough LA Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7.5 mg/5 mL (118 mL): $5.38</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F158841\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Acodin (PL);</li>\n      <li>Acough (HK);</li>\n      <li>Actifed New (BE);</li>\n      <li>Adult Dry Cough (GB);</li>\n      <li>Alex (IN);</li>\n      <li>Altec (VN);</li>\n      <li>Antus (TH);</li>\n      <li>Arilcodiltosse (IT);</li>\n      <li>Aritos (ES);</li>\n      <li>Astomari (JP);</li>\n      <li>Athos (MX);</li>\n      <li>Atos (PE);</li>\n      <li>Atuxane (FR);</li>\n      <li>Balsedrina (MX);</li>\n      <li>Bechilar (IT);</li>\n      <li>Bei Ke Er (CN);</li>\n      <li>Benylin Dry Coughs Syrup (MT);</li>\n      <li>Benylin Non-Drowsy Dry Cough (IE);</li>\n      <li>Biocadextro (FR);</li>\n      <li>Bioquidan (MX);</li>\n      <li>Bisoltussin (BE, BR, HR, ID, PT, VN);</li>\n      <li>Bisolvon Dry (AU);</li>\n      <li>Bisolvon Tosse Sed (IT);</li>\n      <li>Brocolan (MX);</li>\n      <li>Brofex (BD);</li>\n      <li>Bronchenolo Tosse (IT);</li>\n      <li>Bronchetab (IT);</li>\n      <li>Bronchosedal (BE, LU);</li>\n      <li>Bronchydex (FR);</li>\n      <li>Broncogrip (PY);</li>\n      <li>Brudex (MX);</li>\n      <li>Cinfatos (ES);</li>\n      <li>Coldflu (BD);</li>\n      <li>Contrasal (QA, SA);</li>\n      <li>Cortuss (TH);</li>\n      <li>Couldetos (ES);</li>\n      <li>Curatos (PE);</li>\n      <li>Daro Retard (NL);</li>\n      <li>Dekesi (CN);</li>\n      <li>Depan-F (TH);</li>\n      <li>Dexatussin (PL);</li>\n      <li>Dexcophan (HK, SG);</li>\n      <li>Dexir (BE);</li>\n      <li>Dexof (PH);</li>\n      <li>Dexofan (DK, LV, QA, SA);</li>\n      <li>Dexsol (BD);</li>\n      <li>Dextonil (VE);</li>\n      <li>Dextro Toss (UY);</li>\n      <li>Dextrocough (TH);</li>\n      <li>Dextrokuf (ET, QA, SA);</li>\n      <li>Dextrome (HK);</li>\n      <li>Dextrophan (MY);</li>\n      <li>Dextrotos (AR);</li>\n      <li>Diacol (MT, PT);</li>\n      <li>DM (IN);</li>\n      <li>Drikof (BD);</li>\n      <li>Eascof-DM (ET);</li>\n      <li>Ergix Toux Seche (FR);</li>\n      <li>Exedexe (AE, QA, SA);</li>\n      <li>Exophan (BD);</li>\n      <li>Fluditec Dry Cough (LV);</li>\n      <li>Formitrol (IT);</li>\n      <li>Formulatus (ES);</li>\n      <li>Garde (MX);</li>\n      <li>Hihustan (JP);</li>\n      <li>Humisec (RO);</li>\n      <li>Hustenstiller-ratiopharm (DE);</li>\n      <li>Icolid (TH);</li>\n      <li>Jiang Ke (CN);</li>\n      <li>Kafosed (SA);</li>\n      <li>Ke Le Er (CN);</li>\n      <li>KeDi (CN);</li>\n      <li>Kofban (IN);</li>\n      <li>Kofrid (IN);</li>\n      <li>Lafedar (AR);</li>\n      <li>Laitos (ES);</li>\n      <li>Larentel (PT);</li>\n      <li>Lastuss LA (LK);</li>\n      <li>Lexatussin (PE);</li>\n      <li>Lexcof (IN);</li>\n      <li>Libolar (VE);</li>\n      <li>MedDex (CZ);</li>\n      <li>Meddex (HU);</li>\n      <li>Metodex (BD);</li>\n      <li>Metorfan (EC, IT);</li>\n      <li>Metorfan Forte (EC);</li>\n      <li>Mugotussol (SK);</li>\n      <li>Mytusan DM (PH);</li>\n      <li>Nodex (FR);</li>\n      <li>Numark Adult Dry Cough Linctus (MT);</li>\n      <li>Promedin (VE);</li>\n      <li>Pusiran (CN, HK, MY, SG, TH);</li>\n      <li>Quimofan (MX);</li>\n      <li>Resilar (FI);</li>\n      <li>Riaphan (QA, SA);</li>\n      <li>Robitussin (PL);</li>\n      <li>Robitussin Antitussicum (SK);</li>\n      <li>Robitussin Dry Cough (GB, IE, MT);</li>\n      <li>Robitussin Dry Cough Forte (AU);</li>\n      <li>Robitussin Junior (CZ, HU, RO, SK);</li>\n      <li>Rodilar (VN);</li>\n      <li>Rofedex (RO);</li>\n      <li>Rometor (FI);</li>\n      <li>Romilar (ES, ID, MX, TH);</li>\n      <li>Romin (QA, SA);</li>\n      <li>Setustop (PT);</li>\n      <li>Shu De (CN);</li>\n      <li>Silomat DMP (DE);</li>\n      <li>Sisaal (JP);</li>\n      <li>Stopex (CZ, SK);</li>\n      <li>Strepsils Dry Cough (AU, PH);</li>\n      <li>Sumentol (PY);</li>\n      <li>Teratos Miel Adultos (CO);</li>\n      <li>Tilodrin (VE);</li>\n      <li>Tip (ES);</li>\n      <li>Tomephen (BD);</li>\n      <li>Tositec (PY);</li>\n      <li>Tossoral (IT);</li>\n      <li>Touxium Antitussivum (BE, LU);</li>\n      <li>Trimedal Tosse (BR);</li>\n      <li>Tusifan (HR);</li>\n      <li>Tusminal (CL);</li>\n      <li>Tuspulmin (PE);</li>\n      <li>Tussal Antitussicom (PL);</li>\n      <li>Tussastopp (AT);</li>\n      <li>Tussidane (FR);</li>\n      <li>Tussidex (PL, SG);</li>\n      <li>Tussidril (ES);</li>\n      <li>Tussidrill (CZ, PL);</li>\n      <li>Tussils (MY, SG);</li>\n      <li>Tussin (RO);</li>\n      <li>Tussin Forte (RO);</li>\n      <li>Tussipect (ET, NL);</li>\n      <li>Tussis Om (PE);</li>\n      <li>Tussopront (HU);</li>\n      <li>Tussoral (PT);</li>\n      <li>Tussycalm (IT);</li>\n      <li>Tuxium (FR);</li>\n      <li>Vicks MedDex (PL);</li>\n      <li>Vicks Tosse Pastiglie (IT);</li>\n      <li>Vicks Tosse Sedativo (IT);</li>\n      <li>Vicks Vaposyrup Antitussif (BE);</li>\n      <li>Wick Formel 44 Husten-Pastillen S (AT);</li>\n      <li>Wick Formel 44 Hustenstiller (AT)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Abduljalil K, Frank D, Gaedigk A, et al. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. <i>Clin Pharmacol Ther</i>. 2010;88(5):643-651. doi: 10.1038/clpt.2010.137.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/20881950/pubmed\" target=\"_blank\" id=\"20881950\">20881950</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chasnoff IJ, Diggs G, Schnoll SH. Fetal alcohol effects and maternal cough syrup abuse. <i>Am J Dis Child</i>. 1981;135(10):968.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/7197464/pubmed\" target=\"_blank\" id=\"7197464\">7197464</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Conover EA. Herbal agents and over-the-counter medications in pregnancy. <i>Best Pract Res Clin Endocrinol Metab</i>. 2003;17(2):237-251.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/12787550/pubmed\" target=\"_blank\" id=\"12787550\">12787550</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Creomulsion (dextromethorphan hydrobromide syrup) [prescribing information]. Kennesaw, GA: Socius Care, LLC; August 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Delsym and Children's Delsym (dextromethorphan polistirex extended-release suspension) [prescribing information]. Parsippany, NJ: Reckitt Benckiser; September 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hold DM (dextromethorphan hydrobromide lozenge) [package labeling]. Lenexa, KS: B.F. Ascher &amp; Co, Inc.; no date.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Jacqz-Aigrain E and Cresteil T, &quot;Cytochrome P450-Dependent Metabolism of Dextromethorphan: Fetal and Adult Studies,&quot; <i>Dev Pharmacol Ther</i>, 1992, 18(3-4):161-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/1306804/pubmed\" target=\"_blank\" id=\"1306804\">1306804</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Jurica J, Bartecek R, Zourkova A, et al. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice. <i>J Clin Pharm Ther</i>. 2012;37(4):486-490. doi:10.1111/j.1365-2710.2012.01333.x.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/22548589/pubmed\" target=\"_blank\" id=\"22548589\">22548589</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Koren G, Pastuszak A, Ito S. Drugs in pregnancy. <i>N Engl J Med</i>. 1998;338(16):1128-1137.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/9545362/pubmed\" target=\"_blank\" id=\"9545362\">9545362</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Matthys H, Bleicher B, Bleicher U. Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. <i>J Int Med Res</i>. 1983;11(2):92-100.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/6852361/pubmed\" target=\"_blank\" id=\"6852361\">6852361</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Robitussin Lingering Cold Long-Acting CoughGels (dextromethorphan hydrobromide capsule) [prescribing information]. Richmond, VA: Richmond Division of Wyeth, LLC; May 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sager JE, Lutz JD, Foti RS, et al. Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. <i>Clin Pharmacol Ther</i>. 2014;95(6):653-662. doi: 10.1038/clpt.2014.50.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/24569517/pubmed\" target=\"_blank\" id=\"24569517\">24569517</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schwartz AR, Pizon AF, and Brooks DE, &ldquo;Dextromethorphan-Induced Serotonin Syndrome,&rdquo; <i>Clin Toxicol (Phila)</i>, 2008, 46(8):771-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/19238739/pubmed\" target=\"_blank\" id=\"19238739\">19238739</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Scot-Tussin Diabetes (dextromethorphan hydrobromide liquid) [prescribing information]. San Diego, CA: IriSys, LLC; October 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tracy TS, Venkataramanan R, Glover DD, et al, &quot;Temporal Changes in Drug Metabolism (CYP1A2, CYP2D6 and CYP3A Activity) During Pregnancy,&quot; <i>Am J Obstet Gynecol</i>, 2005, 192(2):633-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/15696014/pubmed\" target=\"_blank\" id=\"15696014\">15696014</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Triaminic Long Acting Cough (dextromethorphan hydrobromide syrup) [prescribing information]. Parsippany, NJ: Novartis Consumer Health, Inc; September 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wadelius M, Darj E, Frenne G, et al, &quot;Induction of CYP2D6 in Pregnancy,&quot; <i>Clin Pharmacol Ther</i>, 1997, 62(4):400-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/ 9357391 /pubmed\" target=\"_blank\" id=\" 9357391 \"> 9357391 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ward KE. Can Robitussin DM be used to treat cough during pregnancy? <i>Med Health R I</i>. 2005;88(3):99-100.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/15915786/pubmed\" target=\"_blank\" id=\"15915786\">15915786</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the eleventh WHO model list of essential drugs. 2002. Available at http://www.who.int/maternal_child_adolescent/documents/55732/en/ 9357391 </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. <i>Clin Pharmacokinet</i>. 2009;48(12):761-804. doi:10.2165/11318070.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/dextromethorphan-drug-information/abstract-text/19902987/pubmed\" target=\"_blank\" id=\"19902987\">19902987</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8893 Version 174.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F158845\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F158874\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F158848\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F158862\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F158849\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F49892038\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F49892039\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F158835\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F158824\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F49892050\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F158836\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F158878\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F158830\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F158839\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F5366785\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F158870\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F158831\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F12708268\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F50781259\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F158840\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F158827\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F158838\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323103\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F158841\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8893|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=dextromethorphan-patient-drug-information\" class=\"drug drug_patient\">Dextromethorphan: Patient drug information</a></li><li><a href=\"topic.htm?path=dextromethorphan-pediatric-drug-information\" class=\"drug drug_pediatric\">Dextromethorphan: Pediatric drug information</a></li></ul></div></div>","javascript":null}